Shenzhen Cotran New MaterialLtd Performance dei guadagni passati
Il passato criteri di controllo 4/6
Shenzhen Cotran New MaterialLtd's earnings have been declining at an average annual rate of -27%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 17.1% per year. Shenzhen Cotran New MaterialLtd's return on equity is 4.4%, and it has net margins of 3.2%.
Informazioni chiave
-27.0%
Tasso di crescita degli utili
-27.8%
Tasso di crescita dell'EPS
Chemicals Crescita del settore | 12.1% |
Tasso di crescita dei ricavi | 17.1% |
Rendimento del capitale proprio | 4.4% |
Margine netto | 3.2% |
Ultimo aggiornamento sui guadagni | 30 Sep 2024 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Shenzhen Cotran New Material Co.,Ltd.'s (SZSE:300731) Shares Climb 38% But Its Business Is Yet to Catch Up
Oct 09Subdued Growth No Barrier To Shenzhen Cotran New Material Co.,Ltd. (SZSE:300731) With Shares Advancing 26%
May 24Shenzhen Cotran New MaterialLtd's (SZSE:300731) Performance Is Even Better Than Its Earnings Suggest
May 06What You Can Learn From Shenzhen Cotran New Material Co.,Ltd.'s (SZSE:300731) P/S
Mar 01Ripartizione dei ricavi e delle spese
Come Shenzhen Cotran New MaterialLtd guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
---|---|---|---|---|
30 Sep 24 | 794 | 25 | 90 | 44 |
30 Jun 24 | 694 | 17 | 95 | 43 |
31 Mar 24 | 608 | 32 | 95 | 45 |
31 Dec 23 | 559 | 25 | 93 | 43 |
30 Sep 23 | 504 | 16 | 87 | 36 |
30 Jun 23 | 524 | 6 | 99 | 36 |
31 Mar 23 | 496 | -21 | 103 | 35 |
01 Jan 23 | 520 | -27 | 109 | 37 |
30 Sep 22 | 489 | -68 | 135 | 44 |
30 Jun 22 | 504 | -55 | 122 | 44 |
31 Mar 22 | 536 | -38 | 126 | 43 |
01 Jan 22 | 568 | -13 | 120 | 41 |
30 Sep 21 | 532 | 18 | 107 | 37 |
30 Jun 21 | 449 | 12 | 113 | 31 |
31 Mar 21 | 390 | 32 | 96 | 28 |
31 Dec 20 | 307 | 27 | 91 | 24 |
30 Sep 20 | 299 | 29 | 88 | 23 |
30 Jun 20 | 293 | 56 | 81 | 22 |
31 Mar 20 | 283 | 46 | 82 | 21 |
31 Dec 19 | 306 | 49 | 84 | 20 |
30 Sep 19 | 310 | 56 | 86 | 17 |
30 Jun 19 | 315 | 44 | 75 | 16 |
31 Mar 19 | 305 | 43 | 69 | 14 |
31 Dec 18 | 286 | 44 | 62 | 13 |
30 Sep 18 | 285 | 58 | 49 | 15 |
30 Jun 18 | 274 | 60 | 40 | 20 |
31 Mar 18 | 263 | 63 | 38 | 17 |
31 Dec 17 | 254 | 64 | 38 | 15 |
30 Sep 17 | 225 | 60 | 37 | 9 |
30 Jun 17 | 215 | 60 | 42 | 0 |
31 Mar 17 | 195 | 56 | 38 | 0 |
31 Dec 16 | 188 | 54 | 35 | 0 |
31 Dec 15 | 154 | 35 | 37 | 0 |
31 Dec 14 | 159 | 56 | 21 | 0 |
31 Dec 13 | 88 | 31 | 13 | 0 |
Guadagni di qualità: 300731 has high quality earnings.
Margine di profitto in crescita: 300731's current net profit margins (3.2%) are higher than last year (3.1%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: 300731's earnings have declined by 27% per year over the past 5 years.
Accelerare la crescita: 300731's earnings growth over the past year (60.3%) exceeds its 5-year average (-27% per year).
Guadagni vs Settore: 300731 earnings growth over the past year (60.3%) exceeded the Chemicals industry -3.8%.
Rendimento del capitale proprio
ROE elevato: 300731's Return on Equity (4.4%) is considered low.